Unibest
← Back to patent-cliff list

CAS 163706-52-3

(2R,3R,4R,5R)-2-(6-acetamido-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)-5-(acetoxymethyl)tetrahydrofuran-3,4-diyl diacetate

Codes: CANG-007

Application context (from source-drug indications)

Coronary thrombosisCangrelor TetrasodiumMyocardial infarctionCangrelor TetrasodiumThrombosisCangrelor TetrasodiumAcute coronary syndromeCangrelor TetrasodiumCoronary artery lesionCangrelor TetrasodiumAtherosclerosisCangrelor Tetrasodium

Source drugs (routes using this intermediate)

DrugTierExpiry
Cangrelor TetrasodiumTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Unibest Taizhou GMP-like Site(2R,3S,4R,5R)-2-(hydroxyMethyl)-5-(6-((2-(Methylthio)ethyl)aMino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API WorksPhosphonic acid, P,P'-(dichloromethylene)bis-, compd. with N,N-dibutyl-1-butanamine (1:1)
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.